Vancomycin-Resistant Enterococcus Faecium Infections - Pipeline Insight, 2019 - ResearchAndMarkets.com
The "Vancomycin-Resistant Enterococcus Faecium Infections - Pipeline Insight, 2019" drug pipelines has been added to ResearchAndMarkets.com's offering.
This report offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Vancomycin-Resistant Enterococcus Faecium Infections development.
The report provides detailed coverage of the pipeline landscape for this mechanism of action, equipped with data from multiple sources with complete pipeline analysis by developmental stage, associated indications, route of administration and molecule type.
Pipeline Products covered across the following Developmental Stages:
- Inactive: Discontinued and/or Dormant
Descriptive coverage of pipeline development activities for Vancomycin-Resistant Enterococcus Faecium Infections
Pipeline therapeutics development coverage provides descriptive product profiles including (but not limited to) drug description, product development and R&D activities encompassing clinical and pre-clinical studies, designations, collaborations, licensing deals, grants, technologies and patent details.
Pipeline Therapeutics assessment of products for Vancomycin-Resistant Enterococcus Faecium Infections
The report assesses the active Vancomycin-Resistant Enterococcus Faecium Infections pipeline products by developmental stage, product type, molecule type, and administration route.
1. Report Introduction
2. Vancomycin-Resistant Enterococcus Faecium Infections Overview
3. Pipeline Therapeutics
4. Comparative Analysis
5. Products in Clinical Stage
6. Products in Pre-Clinical & Discovery Stage
7. Therapeutic Assessment
8. Inactive Products
- Alchemia Ltd
- Aphios Corp
- C3J Therapeutics Inc
- Helix BioMedix Inc
- Hsiri Therapeutics LLC
- LegoChem Biosciences Inc
- Lytix Biopharma AS
- MGB Biopharma Ltd
- MicuRx Pharmaceuticals Inc
- Nanotherapeutics Inc
- NovoBiotic Pharmaceuticals LLC
- Oragenics Inc
For more information about this drug pipelines report visit https://www.researchandmarkets.com/research/8dswm4/vancomycinresista?w=4
View source version on businesswire.com: https://www.businesswire.com/news/home/20190122005477/en/